Literature DB >> 3689542

Midazolam: an effective intravenous agent for seizure control.

G M Galvin1, G A Jelinek.   

Abstract

Midazolam meleate, a water soluble 1,4 benzodiazepine, was used intravenously in 20 patients suffering seizures, of whom 12 were in status epilepticus. In all cases, midazolam in a dose of 2.5-15 mg rapidly terminated the seizure. There were no complications from the use of midazolam. The causes of the seizures were varied but alcohol-withdrawal seizures were the single largest cause. Thirteen patients were taking some form of anticonvulsant medication but only three were in the therapeutic range. Midazolam is seen to be an effective agent in the emergency treatment of seizures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689542      PMCID: PMC1285439          DOI: 10.1136/emj.4.3.169

Source DB:  PubMed          Journal:  Arch Emerg Med        ISSN: 0264-4924


  7 in total

1.  Clinical, electroencephalographic, and pharmacokinetic studies of a water-soluble benzodiazepine, midazolam maleate.

Authors:  C R Brown; F H Sarnquist; C A Canup; T A Pedley
Journal:  Anesthesiology       Date:  1979-05       Impact factor: 7.892

2.  Anticonvulsant drugs.

Authors:  D L Davidson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-25

3.  Current concepts in neurology: management of status epilepticus.

Authors:  A V Delgado-Escueta; C Wasterlain; D M Treiman; R J Porter
Journal:  N Engl J Med       Date:  1982-06-03       Impact factor: 91.245

4.  Benzodiazepine receptors and their relationship to the treatment of epilepsy.

Authors:  B S Meldrum; A G Chapman
Journal:  Epilepsia       Date:  1986       Impact factor: 5.864

5.  Potentiation of GABA by midazolam and its therapeutic effect against status epilepticus.

Authors:  S Kaneko; K Kurahashi; S Fujita; Y Fukushima; T Sato; R G Hill
Journal:  Folia Psychiatr Neurol Jpn       Date:  1983

6.  TREATMENT OF STATUS EPILEPTICUS WITH DIAZEPAM (VALIUM).

Authors:  H GASTAUT; R NAQUET; R POIRE; C A TASSINARI
Journal:  Epilepsia       Date:  1965-06       Impact factor: 5.864

7.  Lorazepam in the treatment of refractory neonatal seizures. A pilot study.

Authors:  A Deshmukh; W Wittert; E Schnitzler; H H Mangurten
Journal:  Am J Dis Child       Date:  1986-10
  7 in total
  13 in total

Review 1.  Emergency department drug therapy for status epilepticus in adults.

Authors:  A S Lockey
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

2.  Intramuscular midazolam for treatment of acute seizures or behavioral episodes in patients with brain injuries.

Authors:  B A Wroblewski; A B Joseph
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

3.  Role of neurosteroids in the anticonvulsant activity of midazolam.

Authors:  Ashish Dhir; Michael A Rogawski
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal.

Authors:  Sandesh D Reddy; Doodipala Samba Reddy
Journal:  Epilepsia       Date:  2015-05-29       Impact factor: 5.864

5.  Antiseizure Activity of Midazolam in Mice Lacking δ-Subunit Extrasynaptic GABA(A) Receptors.

Authors:  Sandesh D Reddy; Iyan Younus; Bryan L Clossen; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2015-03-17       Impact factor: 4.030

6.  Continuous midazolam infusion as treatment of status epilepticus.

Authors:  R L Koul; G Raj Aithala; A Chacko; R Joshi; M Seif Elbualy
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

Review 7.  Tonic clonic status epilepticus.

Authors:  S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

Review 8.  Generalized convulsive status epilepticus: pathophysiology and treatment.

Authors:  F B Scholtes; W O Renier; H Meinardi
Journal:  Pharm World Sci       Date:  1993-02-19

Review 9.  Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 10.  Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.

Authors:  Steven J Weintraub
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.